Business Context and Reporting Period
Company: CECO Environmental Corp.
Filing Type: Form 8-K (Current Report)
Date of Report: March 16, 2005
Event: Notice of failure to satisfy Nasdaq continued listing requirements regarding independent directors and audit committee composition.
Key Financial Metrics
This filing does not contain financial data. Revenue, profit, cash flow, margins, debt, and liquidity metrics are not reported in this document.
Material Changes
- Board Composition Change: Josephine Grivas, a former director and audit committee member, passed away on March 7, 2005.
- Listing Compliance Status: The Company received notice from The Nasdaq Stock Market on March 16, 2005, stating it no longer complies with Nasdaq Marketplace Rule 4350 due to the vacancy.
- Specific Deficiencies: The board no longer consists of a majority of independent directors, and the audit committee no longer has the required minimum of three independent directors.
Outlook, Risks, and Management Commentary
- Cure Period: The Company has a cure period until the earlier of its next annual meeting of stockholders or March 7, 2006, to regain compliance.
- Management Action: The Company is currently conducting a search to identify a qualified individual to join the board of directors and the audit committee within the cure period.
- Risk: Failure to regain compliance within the cure period could result in delisting from The Nasdaq Stock Market.
Investor Verification Checklist
- Verify the timeline for the next annual meeting of stockholders to determine the exact expiration of the cure period.
- Monitor subsequent filings for the appointment of a new independent director to the audit committee.
- Review the Company's current board composition to confirm the number of remaining independent directors.